Vancomycin and Therapeutic Drug Monitoring

This presentation examines vancomycin as a critical treatment for serious Gram‑positive infections, explains why individualised therapeutic drug monitoring — particularly AUC/MIC‑guided dosing — is essential for optimising efficacy and reducing nephrotoxicity, and outlines practical strategies for implementing these approaches in clinical practice.